M. Michel Et Al. , "Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes," BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24, pp.4977-4978, 2021
Michel, M. Et Al. 2021. Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes. BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24 , 4977-4978.
Michel, M., Yesilyurt, Z. E., Ozturk, G., & Arioglu-Inan, E., (2021). Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes. BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24, 4977-4978.
Michel, Martin Et Al. "Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes," BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24, 4977-4978, 2021
Michel, Martin Et Al. "Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes." BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24, pp.4977-4978, 2021
Michel, M. Et Al. (2021) . "Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes." BRITISH JOURNAL OF PHARMACOLOGY , vol.178, no.24, pp.4977-4978.
@article{article, author={Martin Michel Et Al. }, title={Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes}, journal={BRITISH JOURNAL OF PHARMACOLOGY}, year=2021, pages={4977-4978} }